A Gene Mutation Signature Predicting Immunotherapy Benefits in Patients With NSCLC
Dong Pan, Angela Hu, Scott Antonia, Chuan‐Yuan Li
Topics & Concepts
MedicineOncologyInternal medicineCohortPembrolizumabMutationImmunotherapyProportional hazards modelGene signatureBiomarkerCandidate geneGeneCancerGeneticsGene expressionBiologyCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisPancreatic and Hepatic Oncology Research